MedTrace Logo

Juice Plus+OMEGA Study

NCT03348553 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-08-06

No results posted yet for this study

Summary

In this randomized, controlled clinical study firstly the bioavailability of fatty acids and micronutrients of JP+® Omega Blend will be analysed. Secondly, the effect of the constituents contained in the nutraceuticals on blood lipid values will be determined. Thirdly, it will be examined, whether a dose-dependent effect of the supplementation of JP+® Omega Blend exists. Fourthly, the effect of a combined consumption of JP+® Omega Blend and Juice Plus+® Orchard, Garden and Vineyard blend (JP+® OGV) is investigated.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

control group

no supplements given for 16 weeks, after 4 week washout of all supplements and dietetic products

DIETARY_SUPPLEMENT

Omega2

2 capsules of JP+® Omega/d for 16 weeks, after 4 week washout of all supplements and dietetic products

DIETARY_SUPPLEMENT

Omega4

4 capsules of JP+® Omega/d for 16 weeks, after 4 week washout of all supplements and dietetic products

DIETARY_SUPPLEMENT

Omega2+OGV

2 capsules of JP+® Omega/d plus 2 capsules each of an encapsulated fruit, vegetable and berry-juice concentrate (6 capsules) for 16 weeks, after 4 week washout of all supplements and dietetic products

Sponsors & Collaborators

  • Medical University of Graz

    collaborator OTHER

  • Green Beat

    lead OTHER

Principal Investigators

  • Manfred Lamprecht, PhD,PhD · Green Beat and Medical University of Graz, Austria

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2019-04-30
Completion
2020-02-03

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03348553 on ClinicalTrials.gov